France medical device regulatory intelligence, Week 17, 2026.
Signals from 2026-04-20 to 2026-04-26, covering safety alerts, regulatory changes, device registrations, market movement, and source activity for France.
France generated 5 qualifying medical device signals during Week 17, 2026. Competitor launches led the week with 3 signals, while EUDAMED EU Device Database was the most active source. The AMYOPIC device by LABORATOIRE PRECILENS is classified as Class IIa and registered with UDI-DI 03666486000766. Withings (France) has registered two medical devices under product code DPS with the FDA.
Key observations
Competitor launches accounted for 3 of 5 qualifying signals, making it the main review lane for the week.
Regulatory changes formed the second-largest cluster, which is useful context for teams separating safety work from regulatory and market monitoring.
EUDAMED EU Device Database contributed 3 signals, so source-level follow-up should start there.
EUDAMED appeared repeatedly in the highlighted signals, which may warrant closer product, manufacturer, or competitor tracking.
Category interpretation
Competitor launches
3 competitor launches appeared in France during Week 17, 2026. Competitor-linked activity is most useful when paired with product codes, indication context, and adjacent safety signals.
Regulatory changes
1 regulatory changes appeared in France during Week 17, 2026. Regulatory-change activity should be checked against ANSM requirements, guidance, and downstream compliance workflows.
Market signals
1 market signals appeared in France during Week 17, 2026. Market signals help connect regulatory monitoring with launch planning, reimbursement, and commercial strategy.
Recommended monitoring focus
Check whether new France regulatory changes affect submission, labeling, vigilance, or post-market workflows.
Review competitor-linked signals for launch timing, market access movement, and product category momentum.
Use market trend signals to brief commercial, strategy, and market access teams alongside regulatory stakeholders.
Source-backed signal evidence
These source-linked items support the weekly analysis above. They are included for verification and follow-up, not as a raw feed export.
EUDAMED EU Device Database·Competitor launches·
EUDAMED: AMYOPIC by LABORATOIRE PRECILENS (Class refdata.risk-class.class-iia)
The AMYOPIC device by LABORATOIRE PRECILENS is classified as Class IIa and registered with UDI-DI 03666486000766.
MedFlux monitors regulators and medical device market sources across priority countries so regulatory, quality, and strategy teams can review changes without manually checking agency databases.